State Street’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,666
| Closed | -$20.4K | – | 4383 |
|
|
2023
Q4 | $20.4K | Hold |
2,666
| – | – | ﹤0.01% | 4341 |
|
|
2023
Q3 | $19.3K | Hold |
2,666
| – | – | ﹤0.01% | 4446 |
|
|
2023
Q2 | $25K | Sell |
2,666
-63
| -2% | -$590 | ﹤0.01% | 4564 |
|
|
2023
Q1 | $45K | Hold |
2,729
| – | – | ﹤0.01% | 4526 |
|
|
2022
Q4 | $73.2K | Sell |
2,729
-697
| -20% | -$18.7K | ﹤0.01% | 4460 |
|
|
2022
Q3 | $181K | Buy |
3,426
+290
| +9% | +$15.3K | ﹤0.01% | 4196 |
|
|
2022
Q2 | $281K | Sell |
3,136
-12,921
| -80% | -$1.16M | ﹤0.01% | 4063 |
|
|
2022
Q1 | $1.39M | Sell |
16,057
-1,397
| -8% | -$121K | ﹤0.01% | 3702 |
|
|
2021
Q4 | $1.6M | Buy |
17,454
+1,820
| +12% | +$167K | ﹤0.01% | 3702 |
|
|
2021
Q3 | $3.16M | Buy |
15,634
+3,144
| +25% | +$636K | ﹤0.01% | 3471 |
|
|
2021
Q2 | $5.81M | Buy |
+12,490
| New | +$5.81M | ﹤0.01% | 3180 |
|